Singapore, Sept. 16 -- Israeli medical technology company P-Cure and Indian healthcare company ARISTION Proton Centre have announced the signing of a binding agreement to deploy P-Cure's compact, synchrotron-based proton therapy systems in India.

ARISTION plans a long-term investment of approximately Rs 1,900 crore to build dedicated proton therapy infrastructure across the country.

The first centre will be established at Sentient Health City, Bengaluru, ARISTION's flagship 660-bed quaternary campus built around integrated artificial intelligence (AI) and augmented care solutions, followed by centres in Kochi and a third major metropolitan city.

Together, the three centres form the initial phase of a wider national proton therapy netwo...